EP
SLDB icon

Essential Partners’s Solid Biosciences SLDB Stock Holding History

Essential Partners’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.9K Hold
263
– – ﹤0.01% 1942
2026
Q2 		$2.63K Sell
263
-2,767
-91% -$21K ﹤0.01% 1860
2026
Q1 		$21.8K Buy
3,030
+2,767
+1,052% +$17.8K 0.01% 894
2025
Q4 		$1.48K Hold
263
– – ﹤0.01% 1903
2025
Q3 		$1.62K Hold
263
– – ﹤0.01% 1860
2025
Q2 		$1.28K Buy
+263
New +$930 ﹤0.01% 1447

Other funds holding SLDB

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Essential Partners's SLDB Position: Q3 2026 in Review

Essential Partners held its Solid Biosciences (SLDB) position steady in Q3 2026 at 263 shares worth $1.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1942.

Essential Partners first reported a position in SLDB in Q2 2025 and has held it in 6 quarters since. The position peaked at $21.8K in Q1 2026. 9 funds tracked by Wall St. Rank hold SLDB as of Q3 2026.

  • Essential Partners held 263 shares of Solid Biosciences worth $1.9K as of Q3 2026.
  • Essential Partners left its Solid Biosciences share count unchanged in Q3 2026.
  • Solid Biosciences made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #1942 holding.
  • Essential Partners first reported a position in Solid Biosciences in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's Solid Biosciences position peaked at $21.8K in Q1 2026.
  • 9 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.